Search for: "Bill H. Brooke" Results 161 - 178 of 178
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still possible under… [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
15 Mar 2008, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
15 Jan 2008, 12:36 am
  As you will note, the following chapter laws are sorted in descending order: CHAPTER Bill No. [read post]
30 Nov 2007, 12:45 am
Selected federal documents below from Gallery Watch.com may include references to government reporrts, Congressional letters, draft bills, and other primary source materials. [read post]
16 Nov 2007, 4:00 am
Filter Corp. a victory on Wednesday when it ruled that one of the patents Zenon Environmental Inc. had sued it over was anticipated: (IPLaw360), Vonage and AT&T likely to settle: (IPBiz), The Federal Trade Commission (FTC) and IP: (Philip Brooks), Patent trolls and the Eastern District of Texas: (Patent Troll Tracker), Seoul Semiconductor Co. [read post]
20 Aug 2007, 2:40 am
Chapters listed below are sorted in decending order (most recent chapter first): CHAPTER Bill No. [read post]
19 Jul 2007, 9:20 am
  More on the matter can be found at Philip Brooks' Patent Infringement Update. [read post]
29 Jun 2007, 11:29 pm
For this movement he succeeded in attaining a most commanding position, and, according to the surmise of Major H. [read post]
21 Jun 2007, 7:20 am
Unwarranted restrictions on the H-1B and L-1 nonimmigrant visa programs. [read post]
15 May 2007, 8:28 pm
Haven't you read the latest Brookings report? [read post]